Free Trial

Monro (MNRO) Financials

Monro logo
$13.72 -0.05 (-0.36%)
As of 05/20/2025 04:00 PM Eastern
Annual Income Statements for Monro

Annual Income Statements for Monro

This table shows Monro's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/30/2024 3/25/2023 3/26/2022
Net Income / (Loss) Attributable to Common Shareholders
38 39 62
Consolidated Net Income / (Loss)
38 39 62
Net Income / (Loss) Continuing Operations
38 39 62
Total Pre-Tax Income
52 57 77
Total Operating Income
71 80 101
Total Gross Profit
452 456 482
Total Revenue
1,277 1,325 1,359
Operating Revenue
1,277 1,325 1,359
Total Cost of Revenue
825 869 877
Operating Cost of Revenue
825 869 877
Total Operating Expenses
381 376 381
Selling, General & Admin Expense
381 376 381
Total Other Income / (Expense), net
-20 -23 -24
Interest Expense
20 23 25
Other Income / (Expense), net
0.46 0.59 0.62
Income Tax Expense
14 18 16
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
-0.66 -0.38 -0.13
Basic Earnings per Share
$1.18 $1.20 $1.82
Weighted Average Basic Shares Outstanding
30.90M 32.14M 33.53M
Diluted Earnings per Share
$1.18 $1.20 $1.81
Weighted Average Diluted Shares Outstanding
31.89M 32.65M 34.04M
Weighted Average Basic & Diluted Shares Outstanding
29.92M 31.42M 33.56M
Cash Dividends to Common per Share
$1.12 $1.12 $1.02

Quarterly Income Statements for Monro

This table shows Monro's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/23/2023 9/23/2023 6/24/2023 3/25/2023 12/24/2022 9/24/2022 6/25/2022
Net Income / (Loss) Attributable to Common Shareholders
4.62 5.68 5.86 4.18 12 13 8.83 1.08 13 13 12
Consolidated Net Income / (Loss)
4.58 5.65 5.86 3.70 12 13 8.83 0.41 13 13 12
Net Income / (Loss) Continuing Operations
4.58 5.65 5.86 3.70 12 13 8.83 0.41 13 13 12
Total Pre-Tax Income
5.82 8.18 8.20 5.69 16 18 12 0.63 18 18 21
Total Operating Income
9.96 13 13 10 21 22 17 6.18 24 23 26
Total Gross Profit
105 106 109 110 113 115 114 104 113 117 122
Total Revenue
306 301 293 310 318 322 327 311 335 330 350
Operating Revenue
306 301 293 310 318 322 327 311 335 330 350
Total Cost of Revenue
201 195 184 200 205 207 213 207 222 213 227
Operating Cost of Revenue
201 195 184 200 205 207 213 207 222 213 227
Total Operating Expenses
95 93 96 100 91 93 97 98 90 93 96
Selling, General & Admin Expense
95 93 96 100 91 93 97 98 90 93 96
Total Other Income / (Expense), net
-4.15 -5.03 -5.05 -4.65 -4.98 -4.77 -5.15 -5.55 -5.85 -5.61 -5.58
Interest Expense
4.25 5.14 5.14 4.95 5.04 4.80 5.21 5.86 5.95 5.71 5.66
Other Income / (Expense), net
0.10 0.11 0.09 0.31 0.06 0.03 0.06 0.32 0.10 0.10 0.08
Income Tax Expense
1.24 2.53 2.33 1.99 4.23 4.72 3.37 0.22 4.96 4.75 8.19
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
-0.03 -0.03 - - -0.09 -0.09 - -0.68 0.10 0.10 0.10
Basic Earnings per Share
$0.15 $0.18 $0.19 $0.12 $0.38 $0.40 $0.28 $0.02 $0.41 $0.40 $0.37
Weighted Average Basic Shares Outstanding
29.95M 29.93M 29.92M 30.90M 30.93M 31.43M 31.42M 32.14M 31.47M 32.20M 33.48M
Diluted Earnings per Share
$0.15 $0.18 $0.19 $0.12 $0.38 $0.40 $0.28 $0.02 $0.41 $0.40 $0.37
Weighted Average Diluted Shares Outstanding
31.27M 31.22M 31.22M 31.89M 32.19M 32.27M 31.95M 32.65M 31.99M 32.73M 33.99M
Weighted Average Basic & Diluted Shares Outstanding
29.95M 29.95M 29.92M 29.92M 29.90M 31.45M 31.42M 31.42M 31.40M 31.46M 32.20M
Cash Dividends to Common per Share
$0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28 $0.28

Annual Cash Flow Statements for Monro

This table details how cash moves in and out of Monro's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/30/2024 3/25/2023 3/26/2022
Net Change in Cash & Equivalents
1.68 -3.06 -22
Net Cash From Operating Activities
125 215 174
Net Cash From Continuing Operating Activities
125 215 174
Net Income / (Loss) Continuing Operations
38 39 62
Consolidated Net Income / (Loss)
38 39 62
Depreciation Expense
72 77 81
Non-Cash Adjustments To Reconcile Net Income
5.04 -0.43 4.16
Changes in Operating Assets and Liabilities, net
10 99 27
Net Cash From Investing Activities
-1.96 27 -110
Net Cash From Continuing Investing Activities
-1.96 27 -110
Purchase of Property, Plant & Equipment
-25 -39 -28
Acquisitions
0.00 -6.69 -83
Sale of Property, Plant & Equipment
2.95 7.22 1.24
Divestitures
21 57 0.00
Other Investing Activities, net
-0.03 8.42 0.12
Net Cash From Financing Activities
-122 -245 -86
Net Cash From Continuing Financing Activities
-122 -245 -86
Repayment of Debt
-198 -269 -220
Repurchase of Common Equity
-44 -97 0.00
Payment of Dividends
-36 -36 -35
Issuance of Debt
156 157 166
Other Financing Activities, net
0.02 0.73 2.14
Cash Interest Paid
20 23 24
Cash Income Taxes Paid
5.28 17 -12

Quarterly Cash Flow Statements for Monro

This table details how cash moves in and out of Monro's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/23/2023 9/23/2023 6/24/2023 3/25/2023 12/24/2022 9/24/2022 6/25/2022
Net Change in Cash & Equivalents
-11 2.19 12 -17 15 -6.26 10 -8.12 3.21 -21 23
Net Cash From Operating Activities
15 63 26 -5.27 32 27 72 44 51 43 77
Net Cash From Continuing Operating Activities
15 63 26 -5.27 32 27 72 44 51 43 77
Net Income / (Loss) Continuing Operations
4.58 5.65 5.86 3.70 12 13 8.83 0.41 13 13 12
Consolidated Net Income / (Loss)
4.58 5.65 5.86 3.70 12 13 8.83 0.41 13 13 12
Depreciation Expense
17 17 18 18 18 18 18 19 19 19 20
Non-Cash Adjustments To Reconcile Net Income
-0.07 -1.16 1.50 4.10 0.41 0.88 -0.36 0.51 -0.41 0.33 -0.86
Changes in Operating Assets and Liabilities, net
-6.84 41 0.53 -31 1.67 -5.32 45 24 19 10 45
Net Cash From Investing Activities
-4.53 8.87 -4.23 -1.67 6.38 -4.04 -2.63 -9.01 -2.37 -11 49
Net Cash From Continuing Investing Activities
-4.53 8.87 -4.23 -1.67 6.38 -4.04 -2.63 -9.01 -2.37 -11 49
Purchase of Property, Plant & Equipment
-6.88 -4.92 -8.88 -6.59 -3.19 -8.03 -7.68 -10 -8.95 -11 -8.21
Sale of Property, Plant & Equipment
2.35 9.63 0.28 0.16 1.07 0.62 1.11 2.80 3.19 0.50 0.72
Other Investing Activities, net
-8.52 4.15 4.37 - - - 3.94 4.38 4.04 - 0.00
Net Cash From Financing Activities
-21 -69 -9.30 -10 -24 -29 -59 -43 -45 -53 -103
Net Cash From Continuing Financing Activities
-21 -69 -9.30 -10 -24 -29 -59 -43 -45 -53 -103
Repayment of Debt
-66 -91 -65 -58 -31 -42 -67 -52 -48 -48 -121
Repurchase of Common Equity
0.42 - - - -44 - - - -26 -54 -17
Payment of Dividends
-8.39 -8.72 -8.71 -8.71 -8.94 -8.93 -8.93 -8.92 -8.92 -9.10 -9.47
Issuance of Debt
53 31 64 56 60 23 17 18 37 58 44

Annual Balance Sheets for Monro

This table presents Monro's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 3/30/2024 3/25/2023 3/26/2022
Total Assets
1,693 1,777 1,871
Total Current Assets
253 258 246
Cash & Equivalents
6.56 4.88 7.95
Accounts Receivable
12 13 15
Inventories, net
154 147 166
Prepaid Expenses
81 93 56
Current Deferred & Refundable Income Taxes
0.00 - -
Plant, Property, & Equipment, net
280 305 315
Total Noncurrent Assets
1,159 1,213 1,311
Noncurrent Note & Lease Receivables
181 217 268
Goodwill
736 736 777
Intangible Assets
13 17 27
Other Noncurrent Operating Assets
229 240 234
Total Liabilities & Shareholders' Equity
1,693 1,777 1,871
Total Liabilities
1,036 1,082 1,089
Total Current Liabilities
455 449 322
Short-Term Debt
38 40 42
Accounts Payable
252 262 132
Accrued Expenses
56 48 49
Current Deferred Revenue
15 15 14
Current Employee Benefit Liabilities
21 16 19
Other Current Liabilities
73 68 63
Total Noncurrent Liabilities
581 633 767
Long-Term Debt
102 105 176
Capital Lease Obligations
249 295 357
Noncurrent Deferred & Payable Income Tax Liabilities
37 31 29
Other Noncurrent Operating Liabilities
192 202 203
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
657 695 783
Total Preferred & Common Equity
657 695 783
Total Common Equity
657 695 783
Common Stock
255 251 245
Retained Earnings
655 654 651
Treasury Stock
-250 -206 -109
Accumulated Other Comprehensive Income / (Loss)
-3.45 -4.12 -4.49
Other Equity Adjustments
0.03 0.03 0.03

Quarterly Balance Sheets for Monro

This table presents Monro's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023
Period end date 12/28/2024 9/28/2024 6/29/2024 12/23/2023 9/23/2023 6/24/2023 12/24/2022 9/24/2022 6/25/2022
Total Assets
1,670 1,681 1,712 1,733 1,727 1,754 1,799 1,789 1,816
Total Current Assets
274 267 278 272 248 251 269 241 247
Cash & Equivalents
10 21 19 24 9.05 15 13 9.79 31
Accounts Receivable
12 13 12 14 14 14 13 13 12
Inventories, net
177 162 162 160 147 141 141 135 129
Prepaid Expenses
72 69 85 72 78 80 101 83 76
Current Deferred & Refundable Income Taxes
2.61 1.56 - 0.81 0.02 - - - -
Plant, Property, & Equipment, net
269 273 276 285 290 300 307 308 308
Total Noncurrent Assets
1,128 1,142 1,158 1,177 1,189 1,203 1,223 1,241 1,260
Noncurrent Note & Lease Receivables
173 179 183 190 197 207 228 237 253
Goodwill
736 736 736 736 736 736 730 730 730
Intangible Assets
11 12 13 14 15 16 17 18 19
Other Noncurrent Operating Assets
207 215 226 236 239 242 245 252 253
Total Liabilities & Shareholders' Equity
1,670 1,681 1,712 1,733 1,727 1,754 1,799 1,789 1,816
Total Liabilities
1,021 1,029 1,058 1,073 1,027 1,059 1,098 1,067 1,046
Total Current Liabilities
508 502 469 487 472 481 427 385 370
Short-Term Debt
39 39 38 39 39 40 40 40 41
Accounts Payable
317 299 279 287 280 276 228 184 156
Accrued Expenses
56 59 53 54 51 53 49 52 51
Current Deferred Revenue
15 15 15 15 15 15 15 15 15
Current Employee Benefit Liabilities
13 20 14 20 14 23 23 15 24
Other Current Liabilities
69 69 68 72 72 71 66 69 67
Total Noncurrent Liabilities
513 528 589 587 554 578 671 682 676
Long-Term Debt
59 62 112 94 55 65 130 130 110
Capital Lease Obligations
233 241 249 260 270 282 308 320 340
Noncurrent Deferred & Payable Income Tax Liabilities
43 40 39 38 35 32 30 27 25
Other Noncurrent Operating Liabilities
179 184 190 195 195 199 203 205 201
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
649 652 654 660 700 695 701 722 770
Total Preferred & Common Equity
649 652 654 660 700 695 701 722 770
Total Common Equity
649 652 654 660 700 695 701 722 770
Common Stock
257 256 255 253 253 251 249 248 246
Retained Earnings
645 649 652 660 657 653 662 658 654
Treasury Stock
-250 -250 -250 -250 -206 -206 -206 -180 -126
Accumulated Other Comprehensive Income / (Loss)
-3.35 -3.38 -3.42 -3.83 -3.93 -4.02 -4.79 -4.69 -4.59
Other Equity Adjustments
0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03

Annual Metrics And Ratios for Monro

This table displays calculated financial ratios and metrics derived from Monro's official financial filings.

Metric 2024 2023 2022
Period end date 3/30/2024 3/25/2023 3/26/2022
Growth Metrics
- - -
Revenue Growth
-3.67% -2.50% 20.75%
EBITDA Growth
-8.45% -14.04% 22.28%
EBIT Growth
-10.53% -21.17% 40.72%
NOPAT Growth
-5.04% -32.50% 43.84%
Net Income Growth
-3.78% -36.58% 79.40%
EPS Growth
-1.67% -33.70% 79.21%
Operating Cash Flow Growth
-41.77% 23.74% -6.03%
Free Cash Flow Firm Growth
-48.36% 531.64% 54.28%
Invested Capital Growth
-8.00% -16.34% 2.83%
Revenue Q/Q Growth
-0.06% -1.28% 1.69%
EBITDA Q/Q Growth
2.18% -4.45% -4.10%
EBIT Q/Q Growth
6.13% -6.36% -7.97%
NOPAT Q/Q Growth
5.03% -14.94% -4.02%
Net Income Q/Q Growth
9.60% -17.37% -4.92%
EPS Q/Q Growth
9.26% -16.08% -4.74%
Operating Cash Flow Q/Q Growth
-28.17% -1.24% 13.62%
Free Cash Flow Firm Q/Q Growth
-24.03% 2.51% 80.36%
Invested Capital Q/Q Growth
1.11% -3.09% -1.44%
Profitability Metrics
- - -
Gross Margin
35.41% 34.42% 35.45%
EBITDA Margin
11.29% 11.87% 13.47%
Operating Margin
5.59% 6.02% 7.45%
EBIT Margin
5.63% 6.06% 7.50%
Profit (Net Income) Margin
2.94% 2.95% 4.53%
Tax Burden Percent
72.42% 68.31% 79.66%
Interest Burden Percent
72.17% 71.15% 75.83%
Effective Tax Rate
27.58% 31.69% 20.34%
Return on Invested Capital (ROIC)
4.77% 4.39% 6.06%
ROIC Less NNEP Spread (ROIC-NNEP)
1.31% 1.32% 2.68%
Return on Net Nonoperating Assets (RNNOA)
0.79% 0.89% 1.98%
Return on Equity (ROE)
5.56% 5.28% 8.03%
Cash Return on Invested Capital (CROIC)
13.09% 22.18% 3.27%
Operating Return on Assets (OROA)
4.14% 4.40% 5.53%
Return on Assets (ROA)
2.17% 2.14% 3.34%
Return on Common Equity (ROCE)
5.56% 5.28% 8.03%
Return on Equity Simple (ROE_SIMPLE)
5.72% 5.62% 7.86%
Net Operating Profit after Tax (NOPAT)
52 54 81
NOPAT Margin
4.05% 4.11% 5.94%
Net Nonoperating Expense Percent (NNEP)
3.46% 3.07% 3.38%
Cost of Revenue to Revenue
64.59% 65.58% 64.55%
SG&A Expenses to Revenue
29.82% 28.40% 27.99%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
29.82% 28.40% 27.99%
Earnings before Interest and Taxes (EBIT)
72 80 102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
144 157 183
Valuation Ratios
- - -
Price to Book Value (P/BV)
1.42 2.11 1.77
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00
Price to Revenue (P/Rev)
0.73 1.11 1.02
Price to Earnings (P/E)
24.39 37.27 22.42
Dividend Yield
3.59% 2.39% 2.47%
Earnings Yield
4.10% 2.68% 4.46%
Enterprise Value to Invested Capital (EV/IC)
1.27 1.69 1.44
Enterprise Value to Revenue (EV/Rev)
1.03 1.44 1.44
Enterprise Value to EBITDA (EV/EBITDA)
9.13 12.10 10.66
Enterprise Value to EBIT (EV/EBIT)
18.30 23.71 19.15
Enterprise Value to NOPAT (EV/NOPAT)
25.44 34.97 24.18
Enterprise Value to Operating Cash Flow (EV/OCF)
10.51 8.86 11.23
Enterprise Value to Free Cash Flow (EV/FCFF)
9.26 6.92 44.79
Leverage & Solvency
- - -
Debt to Equity
0.59 0.63 0.74
Long-Term Debt to Equity
0.54 0.58 0.68
Financial Leverage
0.61 0.68 0.74
Leverage Ratio
2.57 2.47 2.40
Compound Leverage Factor
1.85 1.76 1.82
Debt to Total Capital
37.24% 38.78% 42.39%
Short-Term Debt to Total Capital
3.65% 3.52% 3.10%
Long-Term Debt to Total Capital
33.59% 35.26% 39.29%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
62.76% 61.22% 57.61%
Debt to EBITDA
2.70 2.80 3.15
Net Debt to EBITDA
2.66 2.77 3.10
Long-Term Debt to EBITDA
2.44 2.54 2.92
Debt to NOPAT
7.53 8.08 7.14
Net Debt to NOPAT
7.41 7.99 7.04
Long-Term Debt to NOPAT
6.80 7.35 6.62
Altman Z-Score
1.83 2.10 2.11
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
0.56 0.58 0.76
Quick Ratio
0.04 0.04 0.07
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
142 275 44
Operating Cash Flow to CapEx
555.76% 676.79% 653.48%
Free Cash Flow to Firm to Interest Expense
7.10 11.87 1.77
Operating Cash Flow to Interest Expense
6.26 9.28 7.05
Operating Cash Flow Less CapEx to Interest Expense
5.13 7.91 5.98
Efficiency Ratios
- - -
Asset Turnover
0.74 0.73 0.74
Accounts Receivable Turnover
102.01 94.36 90.26
Inventory Turnover
5.47 5.54 5.34
Fixed Asset Turnover
4.36 4.27 4.23
Accounts Payable Turnover
3.21 4.42 7.18
Days Sales Outstanding (DSO)
3.58 3.87 4.04
Days Inventory Outstanding (DIO)
66.72 65.86 68.33
Days Payable Outstanding (DPO)
113.67 82.66 50.82
Cash Conversion Cycle (CCC)
-43.38 -12.94 21.55
Capital & Investment Metrics
- - -
Invested Capital
1,040 1,130 1,351
Invested Capital Turnover
1.18 1.07 1.02
Increase / (Decrease) in Invested Capital
-90 -221 37
Enterprise Value (EV)
1,316 1,905 1,951
Market Capitalization
932 1,469 1,383
Book Value per Share
$21.96 $22.13 $23.34
Tangible Book Value per Share
($3.11) ($1.85) ($0.61)
Total Capital
1,046 1,135 1,359
Total Debt
390 440 576
Total Long-Term Debt
351 400 534
Net Debt
383 435 568
Capital Expenditures (CapEx)
23 32 27
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-170 -156 -42
Debt-free Net Working Capital (DFNWC)
-164 -151 -34
Net Working Capital (NWC)
-202 -191 -76
Net Nonoperating Expense (NNE)
14 15 19
Net Nonoperating Obligations (NNO)
383 435 568
Total Depreciation and Amortization (D&A)
72 77 81
Debt-free, Cash-free Net Working Capital to Revenue
-13.33% -11.74% -3.11%
Debt-free Net Working Capital to Revenue
-12.82% -11.37% -2.53%
Net Working Capital to Revenue
-15.81% -14.39% -5.63%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$1.18 $1.20 $1.82
Adjusted Weighted Average Basic Shares Outstanding
30.90M 32.14M 33.53M
Adjusted Diluted Earnings per Share
$1.18 $1.20 $1.81
Adjusted Weighted Average Diluted Shares Outstanding
31.89M 32.65M 34.04M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
29.92M 31.42M 33.56M
Normalized Net Operating Profit after Tax (NOPAT)
52 54 81
Normalized NOPAT Margin
4.05% 4.11% 5.94%
Pre Tax Income Margin
4.06% 4.31% 5.69%
Debt Service Ratios
- - -
EBIT to Interest Expense
3.59 3.47 4.14
NOPAT to Interest Expense
2.59 2.35 3.28
EBIT Less CapEx to Interest Expense
2.47 2.10 3.06
NOPAT Less CapEx to Interest Expense
1.46 0.98 2.20
Payout Ratios
- - -
Dividend Payout Ratio
94.50% 93.23% 56.32%
Augmented Payout Ratio
211.73% 341.43% 56.32%

Quarterly Metrics And Ratios for Monro

This table displays calculated financial ratios and metrics derived from Monro's official financial filings.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/23/2023 9/23/2023 6/24/2023 3/25/2023 12/24/2022 9/24/2022 6/25/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.74% -6.43% -10.33% -0.24% -5.23% -2.34% -6.46% -5.24% -1.93% -5.14% 2.26%
EBITDA Growth
-30.90% -23.99% -13.17% 12.16% -8.04% -5.36% -22.91% -22.45% -10.26% -21.42% -3.74%
EBIT Growth
-53.07% -40.54% -23.37% 63.88% -10.44% -5.01% -33.90% -45.64% -12.86% -31.73% -5.82%
NOPAT Growth
-50.53% -44.27% -24.53% 67.90% -8.14% -5.09% -20.80% -74.84% -15.73% -32.69% -23.88%
Net Income Growth
-62.34% -56.13% -33.59% 804.65% -6.63% -1.90% -29.28% -95.25% -19.97% -37.47% -20.39%
EPS Growth
-60.53% -55.00% -32.14% 500.00% -7.32% 0.00% -24.32% -92.00% -14.58% -35.48% -19.57%
Operating Cash Flow Growth
-54.00% 135.40% -64.26% -112.02% -36.83% -38.32% -7.09% -5.80% 104.27% 8.79% 23.11%
Free Cash Flow Firm Growth
-56.40% -44.47% -76.30% -56.79% -30.67% 4.28% 21.06% 1,158.57% 662.11% 621.88% 423.62%
Invested Capital Growth
-5.75% -7.75% -3.02% -8.00% -11.82% -12.25% -13.27% -16.34% -14.91% -10.41% -9.52%
Revenue Q/Q Growth
1.45% 2.80% -5.45% -2.39% -1.38% -1.49% 5.19% -7.27% 1.63% -5.64% 6.56%
EBITDA Q/Q Growth
-11.75% -0.88% 9.40% -27.79% -2.93% 13.23% 41.32% -40.79% -0.11% -7.76% 42.16%
EBIT Q/Q Growth
-24.40% -0.20% 25.32% -50.37% -4.22% 28.62% 168.01% -72.87% 1.58% -10.49% 120.40%
NOPAT Q/Q Growth
-13.93% -3.78% 41.00% -57.64% -3.03% 30.30% 213.66% -76.82% 0.19% 8.74% -0.34%
Net Income Q/Q Growth
-18.84% -3.68% 58.46% -69.60% -5.45% 45.79% 2,058.68% -96.86% -0.66% 5.10% 44.91%
EPS Q/Q Growth
-16.67% -5.26% 58.33% -68.42% -5.00% 42.86% 1,300.00% -95.12% 2.50% 8.11% 48.00%
Operating Cash Flow Q/Q Growth
-76.36% 144.01% 586.77% -116.38% 21.00% -62.95% 63.68% -13.90% 18.15% -44.20% 65.95%
Free Cash Flow Firm Q/Q Growth
-26.28% 118.08% -57.08% -36.82% -6.10% -6.93% -21.74% 1.37% 41.24% 8.05% 784.29%
Invested Capital Q/Q Growth
-0.42% -5.90% -0.52% 1.11% -2.53% -1.08% -5.62% -3.09% -3.01% -2.24% -8.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
34.28% 35.30% 37.24% 35.49% 35.47% 35.70% 34.99% 33.39% 33.85% 35.39% 34.96%
EBITDA Margin
8.89% 10.22% 10.60% 9.16% 12.39% 12.58% 10.95% 8.15% 12.76% 12.99% 13.28%
Operating Margin
3.26% 4.38% 4.52% 3.33% 6.73% 6.94% 5.31% 1.99% 7.11% 7.12% 7.51%
EBIT Margin
3.29% 4.42% 4.55% 3.43% 6.75% 6.95% 5.32% 2.09% 7.14% 7.15% 7.53%
Profit (Net Income) Margin
1.50% 1.87% 2.00% 1.19% 3.83% 4.00% 2.70% 0.13% 3.89% 3.98% 3.57%
Tax Burden Percent
78.77% 69.07% 71.54% 65.01% 74.20% 73.19% 72.37% 64.82% 72.43% 73.44% 60.38%
Interest Burden Percent
57.81% 61.42% 61.44% 53.47% 76.48% 78.56% 70.08% 9.72% 75.15% 75.80% 78.51%
Effective Tax Rate
21.23% 30.93% 28.46% 34.99% 25.80% 26.81% 27.63% 35.18% 27.57% 26.56% 39.62%
Return on Invested Capital (ROIC)
3.11% 3.65% 3.82% 2.55% 5.81% 5.83% 4.36% 1.38% 5.45% 5.54% 4.79%
ROIC Less NNEP Spread (ROIC-NNEP)
2.16% 2.62% 2.86% 1.81% 4.93% 4.99% 3.46% 0.66% 4.65% 4.76% 4.15%
Return on Net Nonoperating Assets (RNNOA)
1.14% 1.31% 1.59% 1.10% 3.02% 2.93% 1.97% 0.45% 3.31% 3.34% 2.88%
Return on Equity (ROE)
4.25% 4.96% 5.42% 3.65% 8.83% 8.76% 6.32% 1.82% 8.76% 8.88% 7.67%
Cash Return on Invested Capital (CROIC)
9.24% 12.14% 7.70% 13.09% 17.04% 17.53% 18.70% 22.18% 21.16% 16.27% 15.83%
Operating Return on Assets (OROA)
2.34% 3.17% 3.26% 2.53% 4.88% 5.12% 3.89% 1.52% 5.20% 5.29% 5.56%
Return on Assets (ROA)
1.07% 1.34% 1.43% 0.88% 2.77% 2.94% 1.97% 0.10% 2.83% 2.95% 2.63%
Return on Common Equity (ROCE)
4.25% 4.96% 5.42% 3.65% 8.83% 8.76% 6.32% 1.82% 8.76% 8.88% 7.67%
Return on Equity Simple (ROE_SIMPLE)
3.05% 4.20% 5.29% 0.00% 5.20% 5.02% 5.09% 0.00% 6.74% 7.00% 7.58%
Net Operating Profit after Tax (NOPAT)
7.85 9.12 9.48 6.72 16 16 13 4.00 17 17 16
NOPAT Margin
2.57% 3.03% 3.23% 2.17% 4.99% 5.08% 3.84% 1.29% 5.15% 5.23% 4.54%
Net Nonoperating Expense Percent (NNEP)
0.95% 1.03% 0.96% 0.74% 0.89% 0.83% 0.90% 0.72% 0.80% 0.78% 0.64%
Return On Investment Capital (ROIC_SIMPLE)
0.80% - - - 1.51% - - - - - -
Cost of Revenue to Revenue
65.72% 64.70% 62.76% 64.51% 64.53% 64.30% 65.01% 66.61% 66.15% 64.61% 65.04%
SG&A Expenses to Revenue
31.02% 30.92% 32.72% 32.16% 28.74% 28.76% 29.68% 31.41% 26.73% 28.28% 27.45%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
31.02% 30.92% 32.72% 32.16% 28.74% 28.76% 29.68% 31.41% 26.73% 28.28% 27.45%
Earnings before Interest and Taxes (EBIT)
10 13 13 11 21 22 17 6.50 24 24 26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
27 31 31 28 39 41 36 25 43 43 46
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.14 1.32 1.09 1.42 1.43 1.23 1.73 2.11 1.93 1.84 1.87
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 70.73
Price to Revenue (P/Rev)
0.61 0.71 0.57 0.73 0.74 0.66 0.92 1.11 1.01 0.99 1.05
Price to Earnings (P/E)
36.46 30.84 20.24 24.39 26.80 23.97 33.46 37.27 28.65 26.30 24.54
Dividend Yield
4.52% 3.88% 4.69% 3.59% 3.74% 4.10% 2.93% 2.39% 2.56% 2.62% 2.48%
Earnings Yield
2.74% 3.24% 4.94% 4.10% 3.73% 4.17% 2.99% 2.68% 3.49% 3.80% 4.08%
Enterprise Value to Invested Capital (EV/IC)
1.10 1.22 1.06 1.27 1.27 1.15 1.47 1.69 1.56 1.50 1.54
Enterprise Value to Revenue (EV/Rev)
0.88 0.97 0.88 1.03 1.03 0.94 1.21 1.44 1.35 1.34 1.39
Enterprise Value to EBITDA (EV/EBITDA)
9.04 9.14 7.85 9.13 9.29 8.40 10.71 12.10 11.03 10.67 10.46
Enterprise Value to EBIT (EV/EBIT)
22.42 20.16 16.13 18.30 19.35 17.28 22.01 23.71 21.18 20.26 18.90
Enterprise Value to NOPAT (EV/NOPAT)
32.00 28.61 22.48 25.44 26.61 23.98 30.52 34.97 28.37 26.91 25.08
Enterprise Value to Operating Cash Flow (EV/OCF)
10.87 10.29 13.83 10.51 7.52 6.29 7.50 8.86 8.35 9.44 10.07
Enterprise Value to Free Cash Flow (EV/FCFF)
11.50 9.62 13.53 9.26 7.01 6.13 7.32 6.92 6.77 8.74 9.25
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.51 0.53 0.61 0.59 0.60 0.52 0.56 0.63 0.68 0.68 0.64
Long-Term Debt to Equity
0.45 0.47 0.55 0.54 0.54 0.46 0.50 0.58 0.62 0.62 0.58
Financial Leverage
0.53 0.50 0.56 0.61 0.61 0.59 0.57 0.68 0.71 0.70 0.69
Leverage Ratio
2.60 2.52 2.57 2.57 2.60 2.47 2.44 2.47 2.49 2.44 2.43
Compound Leverage Factor
1.50 1.55 1.58 1.37 1.99 1.94 1.71 0.24 1.87 1.85 1.90
Debt to Total Capital
33.75% 34.43% 37.86% 37.24% 37.31% 34.21% 35.75% 38.78% 40.54% 40.46% 38.95%
Short-Term Debt to Total Capital
3.95% 3.94% 3.60% 3.65% 3.69% 3.71% 3.69% 3.52% 3.40% 3.34% 3.27%
Long-Term Debt to Total Capital
29.81% 30.49% 34.26% 33.59% 33.62% 30.51% 32.06% 35.26% 37.14% 37.13% 35.68%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
66.25% 65.57% 62.14% 62.76% 62.69% 65.79% 64.25% 61.22% 59.46% 59.54% 61.05%
Debt to EBITDA
2.81 2.64 2.86 2.70 2.78 2.52 2.64 2.80 2.90 2.89 2.71
Net Debt to EBITDA
2.73 2.48 2.73 2.66 2.62 2.46 2.53 2.77 2.82 2.83 2.54
Long-Term Debt to EBITDA
2.49 2.34 2.59 2.44 2.51 2.25 2.36 2.54 2.66 2.65 2.48
Debt to NOPAT
9.96 8.27 8.20 7.53 7.97 7.19 7.51 8.08 7.47 7.29 6.50
Net Debt to NOPAT
9.66 7.77 7.81 7.41 7.49 7.02 7.22 7.99 7.26 7.15 6.09
Long-Term Debt to NOPAT
8.80 7.32 7.42 6.80 7.18 6.41 6.74 7.35 6.84 6.69 5.95
Altman Z-Score
1.55 1.63 1.56 1.71 1.69 1.67 1.82 1.96 1.94 1.96 2.05
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.54 0.53 0.59 0.56 0.56 0.52 0.52 0.58 0.63 0.63 0.67
Quick Ratio
0.04 0.07 0.07 0.04 0.08 0.05 0.06 0.04 0.06 0.06 0.11
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
67 91 42 97 154 164 176 225 222 157 145
Operating Cash Flow to CapEx
326.80% 0.00% 298.08% -81.94% 1,516.08% 358.84% 1,091.46% 572.80% 883.56% 396.39% 1,030.91%
Free Cash Flow to Firm to Interest Expense
15.78 17.69 8.10 19.60 30.47 34.09 33.76 38.32 37.26 27.51 25.67
Operating Cash Flow to Interest Expense
3.48 12.18 4.98 -1.06 6.38 5.54 13.77 7.47 8.56 7.55 13.65
Operating Cash Flow Less CapEx to Interest Expense
2.42 13.10 3.31 -2.36 5.96 3.99 12.51 6.17 7.59 5.65 12.32
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.71 0.72 0.72 0.74 0.72 0.74 0.73 0.73 0.73 0.74 0.74
Accounts Receivable Turnover
91.21 89.17 94.98 102.01 92.56 96.29 100.33 94.36 96.31 94.40 100.25
Inventory Turnover
4.63 5.08 5.25 5.47 5.51 6.02 6.33 5.54 5.69 5.90 6.00
Fixed Asset Turnover
4.38 4.35 4.31 4.36 4.32 4.34 4.29 4.27 4.31 4.33 4.34
Accounts Payable Turnover
2.58 2.71 2.87 3.21 3.23 3.65 3.96 4.42 5.12 5.80 6.41
Days Sales Outstanding (DSO)
4.00 4.09 3.84 3.58 3.94 3.79 3.64 3.87 3.79 3.87 3.64
Days Inventory Outstanding (DIO)
78.83 71.85 69.55 66.72 66.20 60.59 57.63 65.86 64.09 61.88 60.80
Days Payable Outstanding (DPO)
141.34 134.84 127.12 113.67 113.16 99.90 92.18 82.66 71.36 62.94 56.93
Cash Conversion Cycle (CCC)
-58.52 -58.90 -53.72 -43.38 -43.01 -35.52 -30.91 -12.94 -3.47 2.80 7.51
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
969 973 1,035 1,040 1,029 1,055 1,067 1,130 1,166 1,203 1,230
Invested Capital Turnover
1.21 1.21 1.18 1.18 1.16 1.15 1.13 1.07 1.06 1.06 1.06
Increase / (Decrease) in Invested Capital
-59 -82 -32 -90 -138 -147 -163 -221 -204 -140 -129
Enterprise Value (EV)
1,062 1,184 1,094 1,316 1,310 1,214 1,572 1,905 1,817 1,810 1,896
Market Capitalization
742 863 714 932 942 859 1,200 1,469 1,352 1,329 1,435
Book Value per Share
$21.67 $21.79 $21.88 $21.96 $20.98 $22.28 $22.13 $22.13 $22.29 $22.42 $22.94
Tangible Book Value per Share
($3.29) ($3.22) ($3.16) ($3.11) ($2.89) ($1.63) ($1.81) ($1.85) ($1.48) ($0.83) $0.60
Total Capital
980 994 1,053 1,046 1,052 1,064 1,082 1,135 1,179 1,212 1,261
Total Debt
331 342 399 390 393 364 387 440 478 491 491
Total Long-Term Debt
292 303 361 351 354 325 347 400 438 450 450
Net Debt
320 322 380 383 369 355 372 435 465 481 460
Capital Expenditures (CapEx)
4.53 -4.72 8.60 6.43 2.12 7.41 6.57 7.65 5.76 11 7.49
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-206 -216 -171 -170 -200 -194 -205 -156 -132 -114 -112
Debt-free Net Working Capital (DFNWC)
-195 -196 -153 -164 -176 -185 -190 -151 -119 -104 -81
Net Working Capital (NWC)
-234 -235 -191 -202 -215 -225 -230 -191 -159 -144 -122
Net Nonoperating Expense (NNE)
3.27 3.47 3.61 3.02 3.70 3.49 3.73 3.59 4.24 4.12 3.37
Net Nonoperating Obligations (NNO)
320 322 380 383 369 355 372 435 465 481 460
Total Depreciation and Amortization (D&A)
17 17 18 18 18 18 18 19 19 19 20
Debt-free, Cash-free Net Working Capital to Revenue
-16.98% -17.70% -13.78% -13.33% -15.65% -14.99% -15.77% -11.74% -9.81% -8.43% -8.19%
Debt-free Net Working Capital to Revenue
-16.14% -16.00% -12.28% -12.82% -13.78% -14.29% -14.59% -11.37% -8.84% -7.70% -5.95%
Net Working Capital to Revenue
-19.34% -19.20% -15.33% -15.81% -16.82% -17.34% -17.66% -14.39% -11.83% -10.70% -8.96%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.15 $0.18 $0.19 $0.12 $0.38 $0.40 $0.28 $0.02 $0.41 $0.40 $0.37
Adjusted Weighted Average Basic Shares Outstanding
29.95M 29.93M 29.92M 30.90M 30.93M 31.43M 31.42M 32.14M 31.47M 32.20M 33.48M
Adjusted Diluted Earnings per Share
$0.15 $0.18 $0.19 $0.12 $0.38 $0.40 $0.28 $0.02 $0.41 $0.40 $0.37
Adjusted Weighted Average Diluted Shares Outstanding
31.27M 31.22M 31.22M 31.89M 32.19M 32.27M 31.95M 32.65M 31.99M 32.73M 33.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
29.95M 29.95M 29.92M 29.92M 29.90M 31.45M 31.42M 31.42M 31.40M 31.46M 32.20M
Normalized Net Operating Profit after Tax (NOPAT)
7.85 9.12 9.48 6.72 16 16 13 4.00 17 17 16
Normalized NOPAT Margin
2.57% 3.03% 3.23% 2.17% 4.99% 5.08% 3.84% 1.29% 5.15% 5.23% 4.54%
Pre Tax Income Margin
1.90% 2.71% 2.80% 1.84% 5.16% 5.46% 3.73% 0.20% 5.37% 5.42% 5.92%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.37 2.59 2.59 2.15 4.25 4.66 3.34 1.11 4.02 4.13 4.65
NOPAT to Interest Expense
1.85 1.78 1.84 1.36 3.15 3.41 2.41 0.68 2.90 3.02 2.80
EBIT Less CapEx to Interest Expense
1.30 3.51 0.92 0.85 3.83 3.12 2.08 -0.20 3.06 2.23 3.33
NOPAT Less CapEx to Interest Expense
0.78 2.69 0.17 0.06 2.73 1.87 1.15 -0.62 1.93 1.12 1.48
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
174.46% 128.14% 101.99% 94.50% 104.19% 101.58% 101.33% 93.23% 77.12% 71.76% 61.65%
Augmented Payout Ratio
174.46% 290.53% 101.99% 211.73% 232.68% 174.72% 101.33% 341.43% 282.22% 212.76% 91.15%

Frequently Asked Questions About Monro's Financials

When does Monro's fiscal year end?

According to the most recent income statement we have on file, Monro's financial year ends in March. Their financial year 2024 ended on March 30, 2024.

How has Monro's net income changed over the last 2 years?

Monro's net income appears to be on a downward trend, with a most recent value of $37.57 million in 2024, falling from $61.57 million in 2022. The previous period was $39.05 million in 2023. View Monro's forecast to see where analysts expect Monro to go next.

What is Monro's operating income?
Monro's total operating income in 2024 was $71.43 million, based on the following breakdown:
  • Total Gross Profit: $452.10 million
  • Total Operating Expenses: $380.68 million
How has Monro revenue changed over the last 2 years?

Over the last 2 years, Monro's total revenue changed from $1.36 billion in 2022 to $1.28 billion in 2024, a change of -6.1%.

How much debt does Monro have?

Monro's total liabilities were at $1.04 billion at the end of 2024, a 4.2% decrease from 2023, and a 4.8% decrease since 2022.

How much cash does Monro have?

In the past 2 years, Monro's cash and equivalents has ranged from $4.88 million in 2023 to $7.95 million in 2022, and is currently $6.56 million as of their latest financial filing in 2024.

How has Monro's book value per share changed over the last 2 years?

Over the last 2 years, Monro's book value per share changed from 23.34 in 2022 to 21.96 in 2024, a change of -5.9%.



This page (NASDAQ:MNRO) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners